Interius Biotherapeutics
PrivateLast Round
Series B
Jun 3, 2024
Total Funding Raised
$181.55M
Company Overview
Interius is a biotechnology company specializing in innovative gene delivery solutions for the treatment of hematologic malignancies and other cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Interius Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Interius Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 3, 2024 | ||||
| Debt | Oct 20, 2023 | ||||
| Series A | May 18, 2021 | ||||
| Seed | Mar 31, 2020 |
Key People
Founding team and executive leadership
Interius Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series A |
| Agent Capital | Series A, Seed |
| RA Capital Management | Series A |
| Fairmount Funds Management | Series B |
| University of Pennsylvania | Series A, Seed |
| BrightEdge | Series A |
| Tellus BioVentures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2025
Phase 1 trial for INT2104 approved for expansion into Europe.
- Jan 1, 2025
Preparing for first clinical trial of in vivo cell reprogramming vectors.
Interius Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Interius Biotherapeutics's valuation, stock price, and market status.
